← FDA DRUG APPROVALS

FDA ANDA · ANDA089907

ALLAY

Sponsor: IVAX PHARMS

APPLICATION
ANDA089907
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-13
LATEST ACTION
1997-05-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ALLAYDiscontinued
ACETAMINOPHEN 500MG, HYDROCODONE BITARTRATE 5MG · CAPSULE · ORAL

Approval history

1997-05-05Manufacturing (CMC) · Supplement 4AP
1997-01-31Labeling · Supplement 5AP
1991-03-25Labeling · Supplement 1AP
1989-01-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →